Bausch + Lomb Corporation Common Shares (BLCO)

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequen…

Sector

Health Care

Industry

Ophthalmic Goods

Employees

13,000

Website

ir.bausch.com/

Fundamentals

1-day range

$16.95$17.3

Market cap

$5.99B

P/E (trailing)

—

P/E (forward)

15.69

EPS (trailing)

$-0.48

Dividend yield

—

Beta

0.55

Avg. volume

422.6K

Forecasts

12 analyst ratings

Bausch + Lomb Corporation Common Shares Competitors

Chosen by industry and closest market cap.

• BLCO

  Bausch + Lomb Corporation Common Shares

  $17.15

  ▲ 0.12%
  Market cap $5.99BP/E —
  $13.77$18.92
• WRBY

  Warby Parker Inc. Class A Common Stock

  $25

  ▼ 1.07%
  Market cap $3.31BP/E 401.34
  $14.96$31
• EYE

  National Vision Holdings Inc. Common Stock

  $17.37

  ▼ 2.80%
  Market cap $1.80BP/E 34.05
  $14.75$30.02
• LUCY

  Innovative Eyewear Inc. Common Stock

  $0.97

  ▲ 3.08%
  Market cap $5.88MP/E —
  $0.65$2.24
• LUCYW

  Innovative Eyewear Inc. Series A Warrants 8/16/27

  $0.035

  ▼ 16.86%
  Market cap $556.8KP/E —
  $0.0251$0.181
• COO

  The Cooper Companies Inc. Common Stock

  $71.15

  ▲ 0.27%
  Market cap $14.48BP/E 63.74
  $58.89$89.83
• ALC

  Alcon Inc. Ordinary Shares

  $72.03

  ▼ 0.28%
  Market cap $35.08BP/E 44.50
  $47.8$68.34

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• HC Wainwright & Co. Reiterates Buy on Bausch & Lomb, Maintains $21 Price Target
  benzinga · 8/28/2026
• HC Wainwright & Co. Reiterates Buy on Bausch & Lomb, Maintains $21 Price Target
  Benzinga · 8/28/2026
• Bausch + Lomb Advances Two Eye Therapies With Blockbuster Sales Potential
  Benzinga · 8/25/2026
• Bausch + Lomb Corporation (BLCO) Discusses Results and Development Plans for Dual Action Dry Eye Medicine and Lead Ocular Surface Pain Candidate Transcript
  SeekingAlpha · 8/25/2026
• Bausch + Lomb Corporation (BLCO) Discusses Results and Development Plans for Dual Action Dry Eye Medicine and Lead Ocular Surface Pain Candidate - Slideshow
  SeekingAlpha · 8/25/2026
• Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care Engine
  SeekingAlpha · 8/20/2026
• Carl Icahn Trims JetBlue, AEP Stakes While Sitting Out New Stock Bets
  Benzinga · 8/17/2026
• HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $21
  Benzinga · 8/3/2026
• Bausch + Lomb (BLCO) Lifts 2026 Revenue Guidance, Is The Stock Still 57% Undervalued?
  Yahoo · 7/31/2026

• Barbara Trebbi · August 12, 2026 · Grant

  11.8K
• Robert J. Chersi · August 12, 2026 · Grant

  11.8K
• Laurence E. Paul · August 12, 2026 · Grant

  11.8K
• Frederick Munsch · August 10, 2026 · Sale

  52.9K @ $16.78
• VON ESCHENBACH ANDREW C. · August 7, 2026 · Sale

  6.1K @ $16.58
• VON ESCHENBACH ANDREW C. · August 6, 2026 · Sale

  12.5K @ $16.5
• Andrew J. Stewart · August 5, 2026 · Grant

  16.8K
• Frederick Munsch · August 5, 2026 · Grant

  9.1K
• Yehia Hashad · August 5, 2026 · Grant

  21.0K
• Luc Bonnefoy · August 5, 2026 · Grant

  16.8K
• A. Robert D. Bailey · August 5, 2026 · Grant

  33.6K
• Sam Eldessouky · August 5, 2026 · Grant

  50.3K
• Brent L. Saunders · August 5, 2026 · Grant

  281.9K
• Brent L. Saunders · August 5, 2026 · Tax Withholding

  4.2K @ $16.76
• Luc Bonnefoy · June 12, 2026 · Tax Withholding

  1.0K @ $15.08

Institutional Ownership

March 31, 2026

Total shares held

38.20M

Total value held

$583.82M

Institutional holders

95